Pennsylvania dispensary launches state’s first medical cannabis ad campaign

Cresco Yeltrah, one of 12 companies selected to grow and sell medical cannabis in Pennsylvania when it becomes legal, which is expected in 2018, announced it will start a marketing campaign in October 2017, according to the Philadelphia Enquirer.

Charlie Bachtell, CEO of Cresco Labs, who spoke to the Enquirer, said success of the medical cannabis business depends on people determining if they have one of the 17 qualifying illnesses, talking to their physicians about whether cannabis is appropriate, and convincing physicians to take a course that allows them to recommend cannabis to patients—all of which takes time. This explains the advertising running months in advance of medical cannabis being for sale in the state.

The 17 qualifying illnesses include terminal illness, cancer, post-traumatic stress disorder (PTSD), glaucoma, autism, multiple sclerosis, amyotrophic lateral sclerosis, and neuropathic pain or pain that is not treatable with opioids. The Enquirer article did not state whether the medicine was strictly treating pain in all cases, or other symptoms, or the illnesses themselves.

The company will spend $500,000 on billboards, newspapers and social media to get people thinking about cannabis as a medical treatment. The marketing materials were all approved by the state Department of Health.

Cresco Yeltrah will cultivate cannabis in Brookville, PA, 100 miles north of Pittsburgh, and will open retail stores in Butler and Pittsburgh.

Source: Philadelphia Enquirer article

Pennsylvania dispensary launches state’s first medical cannabis ad campaign

About Cannin Investment Group: Your Pot Stocks Experts

Cannin is your trusted resource for pot stocks. Our global team of experts evaluates all emerging pot stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best pot stock investments for 2020.

Use Cannin as your resource for:

Is it too late to invest in pot stocks? No! This is the perfect time to invest.

Market analysts expect the legal cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in pot stocks is now. Are you looking to buy stock in pot companies for 2020? Interested in emerging penny pot stocks? Looking for the best Canadian pot stocks to invest in? We can help.

Are you interested in pot stocks like Curaleaf, Trulieve, Aurora Cannabis, or Canopy Growth?

Predict price movements of pot stocks several hours in advance with our proprietary algorithmic stock trading software.

+25% Gains in 2020
+49.8% Gains in 2019
108% Backtested since 2012

We’re so confident you’ll love our algotrading pot stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best pot stocks – we’ll show you how at cannin.com.

Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks to Buy

Pennsylvania dispensary launches state’s first medical cannabis ad campaign